Nordic Life Sciences A/S: Financial statements 2024
CVR: 41727659
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
Nordic Life Sciences A/S (CVR 41727659) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -10,527,380 and a net result of DKK -11,050,310 compared with DKK -3,272,239 the year before. Equity in the 2024 report amounted to DKK -19,974,999.
- Gross Profit
- DKK -10,527,380
- Profit/Loss
- DKK -11,050,310
- Equity
- DKK -19,974,999
- Total Assets
- DKK 7,062,126
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -10.5M | -11.1M | -20M | - |
| 2023 | - | -4M | -3.3M | -8.9M | - |
| 2022 | - | -2.4M | -5M | -6M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
On February 5, 2024, the company changed its name from Real Canna Denmark ApS to Real Canna Denmark A/S.
As of February 1, 2024, Anders Raft has joined the board of directors of Nordic Life Sciences A/S.
As of February 1, 2024, Pål Anders Nordvi has joined the board of directors of Nordic Life Sciences A/S.
As of February 1, 2024, Jan Hans Mikael Jönsson has joined the board of directors of Nordic Life Sciences A/S.
As of February 1, 2024, Pål Anders Nordvi has stepped down as adm. dir. of Nordic Life Sciences A/S.
About Nordic Life Sciences A/S
Nordic Life Sciences A/S is a Danish company of the type Aktieselskab based in Søndersø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Real Canna Denmark A/S and Real Canna Denmark ApS. The management consists of Erik Sundt. The board consists of Erik Sundt and Pål Anders Nordvi. The company is owned by Erik Sundt. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -8,872,790 and a net result of DKK -9,299,716 compared with DKK -11,050,310 the year before. Equity in the 2025 report amounted to DKK -13,918,223.